<DOC>
	<DOCNO>NCT02255318</DOCNO>
	<brief_summary>The therapeutic management patient cancer often require establishment chamber implantable catheter . Infections main complication catheter . These infection may responsible significant impairment quality life patient , may increase frequency duration hospitalization . The rate mortality infection 17 % . The objective study evaluate efficacy 1.35 % taurolidine lock / 4 % citrate ( TauroLock® ) primary prevention infection related chamber implantable catheter ( IRCIC ) cancer patient receive parenteral nutrition . This , randomize , double-blind clinical trial compare incidence IRCIC patient receive Taurolidine lock concession usual procedure rinse saline ( placebo ) ( pulse rinse 20 mL serum physiological clamping catheter positive pressure ) . The lock instill end session IV treatment ( chemotherapy , parenteral nutrition , transfusion ) closing catheter . The primary endpoint rate IRCIC group .</brief_summary>
	<brief_title>Primary Prevention Infections Related Chambers Implantable Catheter Taurolodine Lock Patients With Cancer Receiving Parenteral Nutrition</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<criteria>Patients age 18 year Patients solid cancer Patients implantable catheter Patients receive parenteral nutrition Patient affiliate social security scheme beneficiary regime Patients refuse participate protocol Patients already receive preventive lock IRCIC Known citrate ( cyclo ) allergy taurolidine Patients take drug know contraindication citrate cyclotaurolidine . Participation another protocol prevention infection associated central venous catheter Patients sign consent Patient status sociolegal protection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Taurolock®</keyword>
	<keyword>infection related chamber implantable catheter</keyword>
	<keyword>patient cancer receive parenteral nutrition</keyword>
</DOC>